Rich Pharmaceuticals, Inc. — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$115.0K

Net Income/Loss (FY2017)

-$1.7M

Total Assets (FY2017)

$37.4K

Total Equity (FY2017)

-$6.4M

Cash Flows from Operating Activities (FY2017)

-$508.5K

Source: Rich Pharmaceuticals, Inc. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.